Deutsche Bank’s Pandion Therapeutics Inc. Common Stock PAND Stock Holding History

Deutsche Bank’s Portfolio PAND Stock Details PAND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-8,381	Closed	-$504K	–	5016
2021 Q1	$504K	Buy	8,381 +3,044	+57%	+$110K	﹤0.01%	3097
2020 Q4	$79K	Buy	5,337 +1,589	+42%	+$22.1K	﹤0.01%	3976
2020 Q3	$43K	Buy	+3,748	New	+$64.1K	﹤0.01%	3950

Deutsche Bank's PAND Position: Q2 2021 in Review

Deutsche Bank sold out of Pandion Therapeutics Inc. Common Stock (PAND) in Q2 2021, closing a stake of 8,381 shares — an estimated $504K sold.

Deutsche Bank first reported a position in PAND in Q3 2020 and held it in 3 quarters. The position peaked at $504K in Q1 2021. 0 funds tracked by Wall St. Rank hold PAND as of Q2 2021.

Deutsche Bank reported no remaining Pandion Therapeutics Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
Deutsche Bank sold 8,381 Pandion Therapeutics Inc. Common Stock shares in Q2 2021, an estimated $504K.
Deutsche Bank first reported a position in Pandion Therapeutics Inc. Common Stock in Q3 2020 and held it in 3 quarters.
Deutsche Bank's Pandion Therapeutics Inc. Common Stock position peaked at $504K in Q1 2021.
0 funds tracked by Wall St. Rank held Pandion Therapeutics Inc. Common Stock as of Q2 2021.

Based on Deutsche Bank's 13F filing for Q2 2021, filed 11 Aug 2021.